Molecular testing in routine surgical pathology is becoming an important component of the workup of many different types of tumors. In fact, in some organ systems, guidelines now suggest that the ...

Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire StrataDx — two well-known pathology testing companies — in a combined ...

The American Society for Clinical Pathology (ASCP) is the first and only national medical organization to call on the federal government to immediately develop and implement a widespread COVID-19 ...

In a recent study published in Nature Communications, researchers establish AnimalGAN as a reliable alternative for generating synthetic pathology data in an effort to ultimately reduce animal testing ...

Please provide your email address to receive an email when new articles are posted on . A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau ...

Laboratory tests play a critical part of the healthcare system. Ordering and billing for these tests, however, is not always cut-and-dry. Compliance with federal laws and rules (like the Clinical ...

Anyone who has endured a COVID-19 test and then counted down the hours until the results arrived knows how important it is to the patient to shrink the wait, and reduce anxiety and time in ...

The Division of Genomic Diagnostics and Bioinformatics has selected GenomOncology's Pathology Workbench and GenomAnalytics to help scale their molecular pathology lab's test volume and analysis, ...

Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a statement issued Friday. The biotechnology company reported revenue of $6.

ROCKVILLE, Md., Feb. 23, 2021 /PRNewswire/ -- The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of ...

The Dubbo community will benefit from an $8.2 million investment by the Minns Labor Government to deliver major upgrades to NSW Health Pathology’s laboratory at Dubbo Health Service.